- Tytuł:
- Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet 23-29 March 2024 403(10432):1141-1152
Czasopismo naukowe